Overview

Bioequivalence Study With Clinical Endpoint for Diclofenac Sodium Topical Gel 1%

Status:
Completed

Trial end date:
2016-06-01

Target enrollment:

Participant gender:

Summary

A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Three-Arm, Multi-Site Study to Evaluate the Therapeutic Equivalence of Diclofenac Sodium Topical Gel 1% (Hi-Tech Pharmacal Co., Inc.) With Voltaren® Gel (Diclofenac Sodium Topical Gel) 1% (Novartis) in Patients With Osteoarthritis of the Knee

Phase:

Phase 3

Details

Lead Sponsor:

Akorn, Inc.

Treatments:

Diclofenac